# Allium saralicum M. Fritsch extract improves cognitive function in male rats with streptozotocin-induced diabetes cognitive impairment

**Authors:** Shima Mohammadi, Leila Karimi-Zandi, Parviz Dousti Kataj

PMC · DOI: 10.22038/ajp.2025.26350 · 2026-01-01

## TL;DR

This study shows that Allium saralicum extract improves memory in diabetic rats by reducing inflammation and boosting brain growth factors.

## Contribution

The study demonstrates the neuroprotective effects of Allium saralicum in a diabetic cognitive impairment model.

## Key findings

- ASRMF extract improved memory performance in diabetic rats.
- Treatment increased IGF-1 and reduced NF-κB in the hippocampus.
- ASRMF lowered blood glucose levels in treated rats.

## Abstract

The chronic metabolic disease diabetes mellitus (DM) dramatically increases the risk of mental illness and cognitive decline. Allium saralicum M. Fritsch (ASRMF) has demonstrated antioxidant, anti-inflammatory, and neuroprotective properties. This study aimed to investigate the effects of ASRMF on memory impairment, Insulin-like growth factor 1(IGF-1) expression, and inflammation in a streptozotocin (STZ)-induced model of cognitive dysfunction.

Male Wistar rats were randomly divided into five groups (n = 7): Control, Sham, STZ, ASRMF extract, and STZ+ASRMF. Memory impairment and hypoglycemia were induced following a single intraperitoneal injection of STZ (60 mg/kg). Twenty-eight days later, animals in the treated groups received oral administration of ASRMF extract (250 mg/kg) daily for 15 consecutive days. Hyperglycemia confirmation occurred through blood glucose measurements on days 3 and 28 post-inductions, and at the end of the experiment in all groups. Spatial learning and memory performance was evaluated using the Morris water maze (MWM). Brain tissue was fixed in formalin and analyzed via immunohistochemical staining to assess IGF-1 and NF-κB levels.

Our results demonstrated that ASRMF extract treatment significantly improved memory performance, which correlated with increased IGF-1 expression and reduced NF-κB in the hippocampus and blood glucose levels. These findings suggest that ASRMF exerts a neuroprotective effect in the diabetic rat model, likely through its anti-inflammatory properties.

This study underscores the therapeutic potential of ASRMF in alleviating cognitive impairment associated with diabetes mellitus. However, further investigations are warranted to elucidate the precise mechanisms underlying its neuroprotective effects.

## Linked entities

- **Genes:** IGF1 (insulin like growth factor 1) [NCBI Gene 3479], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790]
- **Chemicals:** streptozotocin (PubChem CID 29327)
- **Diseases:** diabetes mellitus (MONDO:0005015)

## Full-text entities

- **Genes:** Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}
- **Diseases:** Memory impairment (MESH:D008569), DM (MESH:D003920), cognitive decline (MESH:D003072), inflammation (MESH:D007249), Hyperglycemia (MESH:D006943), mental illness (MESH:D001523), hypoglycemia (MESH:D007003)
- **Chemicals:** STZ (MESH:D013311), blood glucose (MESH:D001786), formalin (MESH:D005557), ASRMF (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12872068/full.md

---
Source: https://tomesphere.com/paper/PMC12872068